Dr Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
| Corrigendum to “Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework” [Respirat. Med. 239 (2025)](S0954611125000575)(10.1016/j.rmed.2025.107995) | 2025 |
|
Dr Simon Doe
| Clinical remission with biologic therapies in severe asthma: a matter of definition | 2024 |
|
Dr Simon Doe
| Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care | 2024 |
|
Dr Simon Doe
| Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry | 2023 |
|
Professor Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
| Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331, (J Cyst Fibros (2022), 21/2(323-331) (S1569199321014089), (10.1016/j.jcf.2021.09.007)) | 2022 |
|
Dr Carlos Echevarria
Dr Simon Doe
Dr Malcolm Brodlie
Professor Christopher Ward
Dr Stephen Bourke
et al. | Elexacaftor-Tezacaftor-Ivacaftor improve Gastro-Oesophageal reflux and Sinonasal symptoms in advanced cystic fibrosis | 2022 |
|
Dr Hafez Al-momani
Professor Christopher Stewart
Rhys Jones
Amaran Krishnan
Dr Andrew Robertson
et al. | Exposure to bile and gastric juice can impact the aerodigestive microbiome in people with cystic fibrosis | 2022 |
|
Dr Simon Doe
| The effect of the COVID-19 pandemic on severe asthma care in Europe: Will care change for good? | 2022 |
|
Dr John Davison
Dr Simon Doe
| A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment | 2021 |
|
Dr Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
Dr Meenakshi Choudhary
Kevin McEleny
et al. | Current status of fertility and family formation in men with cystic fibrosis | 2021 |
|
Dr Stephen Bourke
Dr Simon Doe
| Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial | 2021 |
|
Professor Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
| Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis | 2021 |
|
Kristina Askew
Jade Bamford
Dr Simon Doe
Dr Stephen Bourke
| Current characteristics, challenges and coping strategies of young people with cystic fibrosis as they transition to adulthood | 2017 |
|
Dr Hafez Al-momani
Rhys Jones
Professor Stephen Bourke
Dr Simon Doe
Dr John Perry
et al. | Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis | 2017 |
|
Dr Stephen Bourke
Dr Simon Doe
Dr Alistair Gascoigne
Dr Rachel Quibell
| A service evaluation of an integrated model of palliative care of cystic fibrosis | 2016 |
|
Dr Simon Doe
Dr Stephen Bourke
| Current characteristics, coping strategies and outcomes of young people with cystic fibrosis transitioning to adulthood | 2016 |
|
Gemma Zeybel
Professor Jeffrey Pearson
Amaran Krishnan
Dr Stephen Bourke
Dr Simon Doe
et al. | Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation | 2016 |
|
Dr Hafez Al-momani
Professor Christopher Stewart
Rhys Jones
Amaran Krishnan
Dr Andrew Robertson
et al. | Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients | 2016 |
|
Dr Simon Doe
Dr Stephen Bourke
| Travelling abroad with cystic fibrosis: Assessment of risks and healthcare requirements | 2016 |
|
Dr Stephen Bourke
Dr Simon Doe
Dr Alistair Gascoigne
Dr Rachel Quibell
| A Prospective Cohort Study of Integrated Palliative Care of Cystic Fibrosis (CF) | 2015 |
|
Dr Simon Doe
| A new era in the treatment of cystic fibrosis | 2014 |
|
